Mitigo Injection
Product Images NDC 66794-160

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mitigo (NDC 66794-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Mitigo 1

Mitigo 1
FDA Label Image

Mitigo 10mg mL Carton

Mitigo 10mg mL Carton
FDA Label Image

Mitigo 10mg mL Label

Mitigo 10mg mL Label
FDA Label Image

Mitigo 25mg mL Carton

Mitigo 25mg mL Carton
FDA Label Image

Mitigo 25mg mL Label

Mitigo 25mg mL Label
This is a drug with NDC code 66794-162-02 and is only available via prescription. The drug should be protected from light and not frozen. The solution should not be used if it contains a precipitate that does not disappear when shaken. This drug contains Mumm-"e Sulfate 500mg/20mL (25 mg/0.1 mL). It should not be injected intravenously, intramuscularly or subcutaneously. It is to be used for continuous microinfusion devices via neuraxial administration only. It comes in a 20mL single-dose vial which is preservative-free. Contact 888-822-8431 for more information.*
FDA Label Image

Mitigo Structure

Mitigo Structure

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.